首页>
外国专利>
Resistance to fracture an oral pharmaceutical dosage form comprising a pharmacologically active ingredient opioid antagonist and / or a means, is disgusting, polyalkylene oxide and anionic polymers
Resistance to fracture an oral pharmaceutical dosage form comprising a pharmacologically active ingredient opioid antagonist and / or a means, is disgusting, polyalkylene oxide and anionic polymers
The invention relates to a pharmaceutical dosage form for oral administration, which has a tensile strength of at least 300 N and which contains (I) a pharmacologically active ingredient; (Ii) an opioid antagonist and / or aversion agent; (Iii) a polyalkylene oxide that has an average molecular weight of at least 200,000 g / mol; and (a) which contains (IV) an anionic polymer and / or (b) has storage stability at 40 ° C. for at least 3 months.
展开▼
机译:本发明涉及口服给药的药物剂型,其具有至少300N的拉伸强度并且包含(I)药理活性成分; (ii)阿片类拮抗剂和/或厌恶剂; (Iii)平均分子量为至少200,000 g / mol的聚环氧烷; (a)含有(IV)阴离子聚合物和/或(b)在40℃下至少3个月的保存稳定性。
展开▼